Trademark Overview
On Thursday, April 16, 2026, a trademark application was filed for MYNTEMPA with the United States Patent and Trademark Office. The USPTO has given the MYNTEMPA trademark a serial number of 99769342. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, April 17, 2026. This trademark is owned by Gilead Sciences Ireland UC. The MYNTEMPA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of HIV infection